Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer

NCT06279351 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer

Interventions

DRUG: Thalidomide+cetuximab+FOLFOX/FOLFIRI

Sponsor

Xinqiao Hospital of Chongqing

Collaborators

[object Object]